Insight - Diabetes breakthrough stalled in safety debate

"(Reuters) - It's a dream of medical science that looks tantalizingly within reach: the artificial pancreas, a potential breakthrough treatment for the scourge of type 1 diabetes.

Meant to mimic the function of a real pancreas, the artificial version is a complex device that combines a pager-sized continuous glucose monitor and sensor that tracks blood sugar with a pump that automatically delivers the correct dose of insulin at just the right time.

That technology could make a major difference to the three million Americans with the disease who must vigilantly monitor their blood sugar, even at night, and risk deadly consequences if they are slow to notice a dangerous change.

But it is caught up in America's long-running tug of war between supporters of more rapid medical innovation and those who seek better safety for new devices. A fresh confrontation is about to break open this week as the U.S. Food and Drug Administration lays out a path toward regulatory approval for such devices, expected as early as Thursday."


Related conversations on TuDiabetes:

FDA outlines flexible approaches for artificial pancreas system clinical trials, product approvals

Medtronic Receives IDE Approval from FDA to Conduct ASPIRE In-Home Study of First Insulin Pump with Low Glucose Suspend for US Market

The Artificial Pancreas Advocacy Campaign

Post your Comments! Let the FDA know what you think about the Low Glucose Suspend device!